Form 4: Eli Lilly CEO David Ricks Reports Stock Transfer and Holdings

Eli Lilly CEO David Ricks reported a transfer of shares and updated his beneficial ownership in a recent SEC filing.

Summary

• David Ricks, CEO of Eli Lilly, filed a Form 4 with the SEC detailing changes in his beneficial ownership of company stock.
• On August 20, 2024, 13,727 shares of Eli Lilly common stock were transferred to Mr. Ricks.
• This transfer was part of an annuity payment from a Grantor Retained Annuity Trust (GRAT).
• Mr. Ricks's direct holdings of Eli Lilly common stock are now 469,824 shares.
• He also has indirect holdings of 59,457 shares through a 2022 GRAT, 68,656 shares through another GRAT, and 7,241 shares in a 401(k).
• Mr. Ricks disclaims beneficial ownership of the indirectly held securities except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock transfer, which is neither positive nor negative in itself.

Management Comments

• The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Industry Context

This filing is a routine disclosure of changes in beneficial ownership by a company executive, which is standard practice for publicly traded companies.

Comparison to Industry Standards

• SEC Form 4 filings are a standard requirement for corporate insiders in the United States.
• The reporting of stock transfers and holdings by executives is common across all publicly listed companies.
• The level of detail provided in this filing is consistent with SEC regulations and industry norms.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the CEO's stock ownership.
• The stock transfer does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Eli Lilly, David Ricks, SEC Form 4, Beneficial Ownership, Stock Transfer, Grantor Retained Annuity Trust, Annuity Payment, LLY